Literature DB >> 2310092

Pulmonary rehabilitation in lung disease other than chronic obstructive pulmonary disease.

S Foster1, H M Thomas.   

Abstract

The benefit of pulmonary rehabilitation is well documented for patients with chronic obstructive pulmonary disease (COPD). However, such benefit has not been demonstrated for severely impaired patients with other chronic pulmonary diseases. Occasional non-COPD patients have been admitted to our 4-wk inpatient program. We compared the improvement of these non-COPD patients with that of COPD patients in the same program. Improvement is assessed by a 6-min walk test done at admission and discharge. On the admission 6-min walk test, 32 non-COPD patients had an ambulation distance of 276 +/- 219 ft (SD). At completion of the program, their ambulation distance increased to 574 +/- 367 ft (increase in ambulation 298 +/- 290 ft, P less than 0.0001). Diagnostic subgroups improved to essentially the same extent. The increase in ambulation was not statistically different between non-COPD patients and a series of 317 patients with COPD. Patients severely impaired with chronic pulmonary disease other than COPD benefit from intensive pulmonary rehabilitation, and the degree of improvement is similar to that of COPD patients.

Entities:  

Mesh:

Year:  1990        PMID: 2310092     DOI: 10.1164/ajrccm/141.3.601

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  14 in total

1.  An experimental assessment of the influence of exercise versus social implementation intentions on physical activity during and following pulmonary rehabilitation.

Authors:  Wendy M Rodgers; Anne-Marie Selzler; Robert G Haennel; Siri Holm; Eric Y L Wong; Michael K Stickland
Journal:  J Behav Med       Date:  2013-03-15

2.  Exercise training and inspiratory muscle training in patients with bronchiectasis.

Authors:  C Newall; R A Stockley; S L Hill
Journal:  Thorax       Date:  2005-06-30       Impact factor: 9.139

3.  Cardiorespiratory function before and after aerobic exercise training in patients with interstitial lung disease.

Authors:  Randall E Keyser; Joshua G Woolstenhulme; Lisa M K Chin; Steven D Nathan; Nargues A Weir; Gerilynn Connors; Bart Drinkard; James Lamberti; Leighton Chan
Journal:  J Cardiopulm Rehabil Prev       Date:  2015 Jan-Feb       Impact factor: 2.081

4.  Effect of once weekly pulmonary rehabilitation on exercise tolerance in patients with chronic lung disease.

Authors:  B M O'Neill; D Johnston; N Burrell; J MacMahon
Journal:  Ir J Med Sci       Date:  2001 Oct-Dec       Impact factor: 1.568

5.  Physiological responses to arm exercise in difficult to wean patients with chronic obstructive pulmonary disease.

Authors:  Michele Vitacca; Luca Bianchi; Maria Sarvà; Mara Paneroni; Bruno Balbi
Journal:  Intensive Care Med       Date:  2006-06-13       Impact factor: 17.440

6.  Pulmonary rehabilitation in chronic respiratory insufficiency. 8. Setting up a pulmonary rehabilitation programme.

Authors:  C J Clark
Journal:  Thorax       Date:  1994-03       Impact factor: 9.139

Review 7.  Pulmonary rehabilitation in emphysema.

Authors:  Andrew L Ries; Barry J Make; John J Reilly
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

8.  Effect of 8-week Pulmonary Rehabilitation Program on Dyspnea and Functional Capacity of Patients on Waiting List for Lung Transplantation.

Authors:  Lütfiye Kılıç; Esra Pehlivan; Arif Balcı; Nur Dilek Bakan
Journal:  Turk Thorac J       Date:  2020-03-01

Review 9.  New modalities of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease.

Authors:  Martijn A Spruit; Emiel F M Wouters
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

10.  The benefits of exercise training in interstitial lung disease: protocol for a multicentre randomised controlled trial.

Authors:  Leona Dowman; Christine F McDonald; Catherine Hill; Annemarie Lee; Kathryn Barker; Claire Boote; Ian Glaspole; Nicole Goh; Annemarie Southcott; Angela Burge; Rebecca Ndongo; Alicia Martin; Anne E Holland
Journal:  BMC Pulm Med       Date:  2013-02-01       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.